Total Payments
$8,243
2024 Payments
$623.33
Companies
43
Transactions
210
Medicare Patients
14,585
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$6,067 (73.6%)
Travel$2,176 (26.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,067 | 203 | 73.6% |
| Travel and Lodging | $2,176 | 7 | 26.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,157 | 31 | $0 (2020) |
| Abbott Laboratories | $1,034 | 19 | $0 (2024) |
| Medtronic Vascular, Inc. | $649.73 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $366.60 | 17 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $341.10 | 20 | $0 (2024) |
| ABIOMED | $312.39 | 4 | $0 (2024) |
| PFIZER INC. | $231.88 | 13 | $0 (2024) |
| Boston Scientific Corporation | $197.90 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $157.36 | 10 | $0 (2024) |
| ATRICURE, INC. | $145.97 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.33 | 31 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($116.12) |
| 2023 | $503.73 | 22 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($77.15) |
| 2022 | $758.35 | 25 | Abbott Laboratories ($215.12) |
| 2021 | $599.14 | 23 | BOSTON SCIENTIFIC CORPORATION ($116.64) |
| 2020 | $614.67 | 17 | Abbott Laboratories ($337.39) |
| 2019 | $2,373 | 33 | Edwards Lifesciences Corporation ($1,465) |
| 2018 | $2,272 | 38 | Edwards Lifesciences Corporation ($1,545) |
| 2017 | $498.73 | 21 | Edwards Lifesciences Corporation ($128.27) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Genetic Disease | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Obesity | ||||||
| 09/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/13/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Genetic Disease | ||||||
| 09/10/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 08/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.43 | General |
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Coronary | ||||||
| 07/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: Cardiology | ||||||
| 06/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Abbott Laboratories | COROFLOW (Device) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Vascular | ||||||
| 04/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,092 | 31,645 | $1.8M | $590,423 |
| 2022 | 50 | 3,731 | 32,003 | $1.6M | $528,200 |
| 2021 | 50 | 3,360 | 44,450 | $1.6M | $492,823 |
| 2020 | 51 | 3,402 | 36,380 | $1.5M | $457,360 |
Total Patients
14,585
Total Services
144,478
Medicare Billing
$2.1M
Procedure Codes
204
All Medicare Procedures & Services
204 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 286 | 2,003 | $170,255 | $93,668 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 455 | 741 | $155,610 | $67,523 | 43.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 246 | 1,633 | $212,290 | $61,855 | 29.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 33 | 33 | $90,190 | $35,809 | 39.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 19 | 19 | $89,300 | $35,636 | 39.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 207 | 653 | $71,830 | $24,700 | 34.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 52 | 104 | $60,840 | $24,373 | 40.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 148 | 152 | $129,200 | $22,024 | 17.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 147 | 149 | $76,735 | $21,450 | 28.0% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 72 | 72 | $85,200 | $15,483 | 18.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 39 | 39 | $42,900 | $13,311 | 31.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 77 | 308 | $29,260 | $12,992 | 44.4% |
| 74175 | Ct scan of blood vessels of abdomen with contrast | Office | 2023 | 54 | 54 | $56,700 | $11,108 | 19.6% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 67 | 67 | $72,360 | $10,502 | 14.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 127 | 276 | $22,080 | $10,218 | 46.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 20 | 24 | $29,280 | $9,988 | 34.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 155 | 157 | $28,260 | $8,496 | 30.1% |
| 75572 | Ct scan of heart structure with contrast | Office | 2023 | 42 | 42 | $21,450 | $7,582 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 57 | $20,520 | $7,514 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 110 | $16,500 | $7,028 | 42.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 77 | $13,706 | $7,008 | 51.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 39 | 78 | $14,820 | $6,777 | 45.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 47 | 47 | $23,030 | $6,587 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 109 | $13,625 | $6,586 | 48.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 34 | 34 | $15,810 | $6,321 | 40.0% |
About Dr. Darryn Appleton, M.D
Dr. Darryn Appleton, M.D is a Cardiovascular Disease healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740497007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darryn Appleton, M.D has received a total of $8,243 in payments from pharmaceutical and medical device companies, with $623.33 received in 2024. These payments were reported across 210 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,067).
As a Medicare-enrolled provider, Appleton has provided services to 14,585 Medicare beneficiaries, totaling 144,478 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 204 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Richmond, VA
- Active Since 05/17/2007
- Last Updated 04/28/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1740497007
Products in Payments
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $3,157
- LifeVest (Device) $341.10
- Xience Sierra Coronary Stent System (Device) $318.32
- Impella (Device) $312.39
- Resolute (Device) $291.39
- ENTRESTO (Drug) $239.84
- ELIQUIS (Drug) $207.87
- CoreValve Evolut (Device) $203.26
- XIENCE SIERRA (Device) $189.77
- Optis Coronary Imaging System (Device) $159.62
- XARELTO (Drug) $157.36
- LEQVIO (Drug) $126.76
- CardioMEMS HF System (Device) $121.32
- Xience Alpine cornary stent system (Device) $116.71
- SYNERGY (Device) $116.64
- JARDIANCE (Drug) $101.83
- 3F (Device) $98.59
- Ozempic (Drug) $88.38
- ENROUTE Transcarotid Neuroprotection System (Device) $81.27
- Repatha (Biological) $78.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Richmond
Dr. Kenneth Ellenbogen, Md, MD
Cardiovascular Disease — Payments: $520,094
Cardiovascular Disease $520,094
Dr. Charles Joyner, M.d, M.D
Cardiovascular Disease — Payments: $138,181
Cardiovascular Disease $138,181
Dr. Jayanthi Koneru, Md, MD
Cardiovascular Disease — Payments: $129,716
Cardiovascular Disease $129,716
Dr. John Mcginty, M.d, M.D
Cardiovascular Disease — Payments: $78,823
Cardiovascular Disease $78,823
Dr. Carolyn Burns, M.d, M.D
Cardiovascular Disease — Payments: $67,223
Cardiovascular Disease $67,223
Jacob Blackwell, M.d, M.D
Cardiovascular Disease — Payments: $44,687
Cardiovascular Disease $44,687